Medline Completes Upsized Sale of 72.6M Shares at $37 Each
MDLN•Medline closed an upsized secondary offering of 72,554,594 Class A shares at $37.00 per share, with underwriters granted a 30-day option on up to 10,883,189 additional shares. Selling stockholders including Blackstone, Hellman & Friedman and ADIA executed the sale, with Medline issuing no shares and receiving no proceeds.
1. Offering Size and Terms
The offering comprised 72,554,594 Class A common shares sold by existing shareholders at $37.00 per share, with underwriters granted a 30-day option to purchase up to 10,883,189 additional shares.
2. Seller Affiliations and Proceeds
Shares were sold exclusively by stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a subsidiary of the Abu Dhabi Investment Authority, with Medline issuing no shares and receiving none of the offering proceeds.
3. Underwriting Syndicate
Goldman Sachs, Morgan Stanley, BofA Securities and J.P. Morgan served as global coordinators and joint bookrunners, supported by a syndicate including Barclays, Citigroup, Deutsche Bank, Jefferies, UBS and an extensive list of co-managers.
